1
TÍTULO: Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
AUTORES: Bellini, Angela; Poetschger, Ulrike; Bernard, Virginie; Lapouble, Eve; Baulande, Sylvain; Ambros, Peter F.; Auger, Nathalie; Beiske, Klaus; Bernkopf, Marie; Betts, David R.; Bhalshankar, Jaydutt; Bown, Nick; de Preter, Katleen; Clement, Nathalie; Combaret, Valerie; de Mora, Jaime Font; George, Sally L.; Jimenez, Irene; Jeison, Marta; Marques, Barbara; Martinsson, Tommy; Mazzocco, Katia; Morini, Martina; Muehlethaler Mottet, Annick; Noguera, Rosa; Pierron, Gaelle; Rossing, Maria; Taschner Mandl, Sabine; Van Roy, Nadine; Vicha, Ales; Chesler, Louis; Balwierz, Walentyna; Castel, Victoria; Elliott, Martin; Kogner, Per; Laureys, Genevieve; Luksch, Roberto; Malis, Josef; Popovic Beck, Maja; Ash, Shifra; Delattre, Olivier; Valteau Couanet, Dominique; Tweddle, Deborah A.; Ladenstein, Ruth; Schleiermacher, Gudrun; ...Mais
PUBLICAÇÃO: 2021, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 39, NÚMERO: 30
INDEXADO EM: WOS
2
TÍTULO: Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study
AUTORES: Keith Holmes; Ulrike Poetschger; Andrew D J Pearson; Sabine Sarnacki; Giovanni Cecchetto; Javier Gomez Chacon; Roly Squire; Enrique Freud; Adam Bysiek; Lucas E Matthyssens; Martin Metzelder; Tom Monclair; Jakob Stenman; Michal Rygl; Lars Rasmussen; Jean Marc Joseph; Sabine Irtan; Stefano Avanzini; Jan Godzinski; Kristin Bjornland; Martin Elliott; Roberto Luksch; Victoria Castel; Shifra Ash; Walentyna Balwierz; Genevieve Laureys; Ellen Ruud; Vassilios Papadakis; Josef Malis; Cormac Owens; Henrik Schroeder; Maja Beck Popovic; Toby Trahair; Ana Forjaz de Lacerda; Peter F Ambros; Mark N Gaze; Kieran McHugh; Dominique Valteau Couanet; Ruth Lydia Ladenstein; ...Mais
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, NÚMERO: 25
INDEXADO EM: Scopus WOS
3
TÍTULO: Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial  Full Text
AUTORES: Ruth Ladenstein; Ulrike Poetschger; Andrew D J Pearson; Penelope Brock; Roberto Luksch; Victoria Castel; Isaac Yaniv; Vassilios Papadakis; Genevieve Laureys; Josef Malis; Walentyna Balwierz; Ellen Ruud; Per Kogner; Henrik Schroeder; Ana Forjaz de Lacerda; Maja Beck Popovic; Pavel Bician; Miklos Garami; Toby Trahair; Adela Canete; Peter F Ambros; Keith Holmes; Mark Gaze; Guenter Schreier; Alberto Garaventa; Gilles Vassal; Jean Michon; Dominique Valteau Couanet; ...Mais
PUBLICAÇÃO: 2017, FONTE: LANCET ONCOLOGY, VOLUME: 18, NÚMERO: 4
INDEXADO EM: WOS
4
TÍTULO: Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study
AUTORES: Ruth Ladenstein; Dominique Valteau Couanet; Penelope Brock; Isaac Yaniv; Victoria Castel; Genevieve Laureys; Josef Malis; Vassilios Papadakis; Ana Lacerda; Ellen Ruud; Per Kogner; Miklos Garami; Walentyna Balwierz; Henrik Schroeder; Maja Beck Popovic; Guenter Schreier; David Machin; Ulrike Potschger; Andrew Pearson;
PUBLICAÇÃO: 2010, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 28, NÚMERO: 21
INDEXADO EM: WOS CrossRef